Related references
Note: Only part of the references are listed.[18F]flutemetamol amyloid positron emission tomography in preclinical and symptomatic Alzheimer's disease: Specific detection of advanced phases of amyloid-β pathology
Dietmar Rudolf Thal et al.
ALZHEIMERS & DEMENTIA (2015)
CSF biomarkers for the differential diagnosis of Alzheimer's disease: A large-scale international multicenter study
Michael Ewers et al.
ALZHEIMERS & DEMENTIA (2015)
Cerebrospinal fluid tau levels are a marker for molecular subtype in sporadic Creutzfeldt-Jakob disease
Andre Karch et al.
NEUROBIOLOGY OF AGING (2015)
Role of Amyloid from a Multiple Sclerosis Perspective: A Literature Review
Avinash Chandra
NEUROIMMUNOMODULATION (2015)
Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease
Sebastian Palmqvist et al.
NEUROLOGY (2015)
Amyloid biomarkers in Alzheimer's disease
Kai Blennow et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Chronic Optogenetic Activation Augments Aβ Pathology in a Mouse Model of Alzheimer Disease
Kaoru Yamamoto et al.
CELL REPORTS (2015)
Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease
Niklas Mattsson et al.
BRAIN (2015)
The cerebrospinal fluid Alzheimer profile: Easily said, but what does it mean?
Flora H. Duits et al.
ALZHEIMERS & DEMENTIA (2014)
Differences in nucleation behavior underlie the contrasting aggregation kinetics of the Aβ40 and Aβ42 peptides
Georg Meisl et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Accuracy of Brain Amyloid Detection in Clinical Practice Using Cerebrospinal Fluid β-Amyloid 42 A Cross-Validation Study Against Amyloid Positron Emission Tomography
Sebastian Palmqvist et al.
JAMA NEUROLOGY (2014)
Comparing Positron Emission Tomography Imaging and Cerebrospinal Fluid Measurements of β-Amyloid
Susan M. Landau et al.
ANNALS OF NEUROLOGY (2013)
Implementation and Validation of an Adaptive Template Registration Method for 18F-Flutemetamol Imaging Data
Roger Lundqvist et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
CSF biomarker associations with change in hippocampal volume and precuneus thickness: implications for the Alzheimer's pathological cascade
Nikki H. Stricker et al.
BRAIN IMAGING AND BEHAVIOR (2012)
Cerebrospinal fluid amyloid-β 2-42 is decreased in Alzheimer's, but not in frontotemporal dementia
Mirko Bibl et al.
JOURNAL OF NEURAL TRANSMISSION (2012)
An automated tool for detection of FLAIR-hyperintense white-matter lesions in Multiple Sclerosis
Paul Schmidt et al.
NEUROIMAGE (2012)
Association Between In Vivo Fluorine 18-Labeled Flutemetamol Amyloid Positron Emission Tomography Imaging and In Vivo Cerebral Cortical Histopathology
David A. Wolk et al.
ARCHIVES OF NEUROLOGY (2011)
pROC: an open-source package for R and S plus to analyze and compare ROC curves
Xavier Robin et al.
BMC BIOINFORMATICS (2011)
CSF amyloid β38 as a novel diagnostic marker for dementia with Lewy bodies
Ezra Mulugeta et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)
Aβ40 and Aβ42 Amyloid Fibrils Exhibit Distinct Molecular Recycling Properties
Laia Sanchez et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)
A novel pathway for amyloid precursor protein processing
Erik Portelius et al.
NEUROBIOLOGY OF AGING (2011)
Evaluation of CSF Biomarkers as Predictors of Alzheimer's Disease: A Clinical Follow-Up Study of 4.7 Years
Joakim Hertze et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
Kaj Blennow et al.
NATURE REVIEWS NEUROLOGY (2010)
Effects of cerebrovascular disease on amyloid precursor protein metabolites in cerebrospinal fluid
Per Selnes et al.
FLUIDS AND BARRIERS OF THE CNS (2010)
Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain
Tero Tapiola et al.
ARCHIVES OF NEUROLOGY (2009)
CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
Niklas Mattsson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease
Milos D. Ikonomovic et al.
BRAIN (2008)
Characterization of amyloid ß peptides in cerebrospinal fluid by an automated immunoprecipitation procedure followed by mass spectrometry
Erik Portelius et al.
JOURNAL OF PROTEOME RESEARCH (2007)
Prediction of Alzheimer's disease using the CSF A beta 42/A beta 40 ratio in patients with mild cognitive impairment
Oskar Hansson et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2007)
Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study
O Hansson et al.
LANCET NEUROLOGY (2006)
Synaptic activity regulates interstitial fluid amyloid-β levels in vivo
JR Cirrito et al.
NEURON (2005)
Amyloid-beta precursor protein processing in neurodegeneration
V Wilquet et al.
CURRENT OPINION IN NEUROBIOLOGY (2004)
CSF Aβ 42 levels correlate with amyloid-neuropathology in a population-based autopsy study
D Strozyk et al.
NEUROLOGY (2003)
Cerebrospinal fluid aβ42 is reduced in multiple system atrophy but normal in Parkinson's disease and progressive supranuclear palsy
B Holmberg et al.
MOVEMENT DISORDERS (2003)
Attention and fluctuating attention in patients with dementia with lewy bodies and Alzheimer disease
C Ballard et al.
ARCHIVES OF NEUROLOGY (2001)
Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke
C Hesse et al.
NEUROSCIENCE LETTERS (2001)
Share Paper
